Sun J S, Liu H C, Chang W H, Li J, Lin F H, Tai H C
Department of Orthopedic Surgery, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, ROC.
J Biomed Mater Res. 1998 Mar 5;39(3):390-7. doi: 10.1002/(sici)1097-4636(19980305)39:3<390::aid-jbm7>3.0.co;2-e.
Over the past decade, a large number of biomaterials have been proposed as artificial bone fillers for repairing bone defects. The material most widely used in clinical medicine is hydroxyapatite. The aim of our investigation was to study the effect of hydroxyapatite size mechanism on osteoblasts. The osteoblasts were cultured in vitro with 0.1% (1 mg/mL) of various sized hydroxyapatite particles (0.5-3.0, 37-63, 177-250, and 420-841 microm) for 1 h, 3 h, 1 day, 3 days, and 7 days. The results showed that adding hydroxyapatite particles to osteoblast cultures can significantly affect osteoblast cell count. Osteoblast populations decreased significantly. Osteoblast mean surface areas also changed significantly. Transforming growth factor-beta1 (TGF-beta1) concentrations in culture medium decreased significantly with the addition of hydroxyapatite particles. Prostaglandin E2 (PGE2) concentrations in medium increased significantly. The changes in TGF-beta1 and PGE2 concentration were more significant and persisted longer in smaller-particle groups. The inhibitory effects of hydroxyapatite particles on osteoblast cell cultures were mediated by the increased synthesis of PGE2. Caution should be exercised before using a hydroxyapatite product which could easily break down into fine particles.
在过去十年中,大量生物材料被提议作为修复骨缺损的人工骨填充剂。临床医学中使用最广泛的材料是羟基磷灰石。我们研究的目的是探讨羟基磷灰石粒径机制对成骨细胞的影响。将成骨细胞与0.1%(1毫克/毫升)不同粒径的羟基磷灰石颗粒(0.5 - 3.0、37 - 63、177 - 250和420 - 841微米)在体外培养1小时、3小时、1天、3天和7天。结果表明,向成骨细胞培养物中添加羟基磷灰石颗粒可显著影响成骨细胞数量。成骨细胞数量显著减少。成骨细胞平均表面积也有显著变化。添加羟基磷灰石颗粒后,培养基中转化生长因子-β1(TGF-β1)浓度显著降低。培养基中前列腺素E2(PGE2)浓度显著升高。在较小颗粒组中,TGF-β1和PGE2浓度的变化更显著且持续时间更长。羟基磷灰石颗粒对成骨细胞培养物的抑制作用是由PGE2合成增加介导的。在使用可能容易分解成细颗粒的羟基磷灰石产品之前应谨慎。